Request a Proposal  
Infectious-disease[hero-optimized]

Infectious Disease CRO & Vaccine CRO Services

Offering global CRO services in support of clinical research for emerging and re-emerging diseases.

Infectious-disease[hero-optimized]

Pharm-Olam Supporting COVID-19 Research

Pharm-Olam stands with the global community and the fight against COVID-19. No other disease in recent history has captured the world like Coronavirus. As an Infectious Disease CRO and Vaccine CRO, we are poised to help pharmaceutical and biotechs by rapidly deploying their clinical trials in the search for vaccines and therapies to fight this infectious disease. Together, we can create a healthier world.

-

Infectious Disease & Vaccine By The Numbers

Pharm-Olam
0
NUMBER OF STUDIES
Pharm-Olam
0
NUMBER OF PATIENTS
Pharm-Olam
0
NUMBER OF SITES

Global Infectious Disease & Vaccine Expertise

US Government Federal Research

We have supported federally-funded research for more than 20 years. We can support your organization's effort to secure government funding.  Our proven track record has allowed us to collaborate on over $778M in government-funded trials with several agencies including the NIH, DOD, BARDA, and CDC.  

Learn More

Expeditionary CRO

As an infectious disease CRO and vaccine CRO, we often have to bring our clinical research efforts to the patients where they are. Our Expeditionary capabilities allow us to add over 30 additional countries to our global coverage. We leverage our staff with strategically-advantageous site relationships and partner networks to reach patients in remote regions.

Learn More

Emerging/Re-emerging

Today it's the coronavirus COVID-19. Tomorrow, it will be something else. Pharm-Olam maintains staff with deep expertise in infectious diseases and vaccines. Roughly 84% of PMs and 79% of CRAs have ID&V expertise. We are ready to go the distance to support finding new vaccines and therapeutics.  

Antibiotic CRO Legacy

As an Infectious Disease CRO, we have deep roots in supporting anti-infective development. Our long and successful history in the anti-infective area of drug development is demonstrated by supporting more than 50% of all NCE antibiotics approved by FDA since 2013.

Pharm-Olam

Sponsor Testimonial

“Working with Pharm-Olam was an absolute pleasure. The entire team was very knowledgeable, professional and customer focused. They showed an excellent level of organization and were always on top of any issues.”

Biotech - Director ClinOps

Wide-Ranging Infectious Disease & Vaccine Expertise

It’s important to choose a team that has the right kind of therapeutic experience for your clinical trial. Our teams have executed studies for infectious disease and vaccine treatments across a wide variety of indications:

Abdominal infections
Bronchiectasis
C. difficile
Cellulitis
Common cold
COVID-19
Hepatitis B
Hepatitis C
HIV
Impetigo
Influenza
Intra-abdominal infection
Otitis media
Pneumonia
Prosthetic joint infection
RSV
Sepsis/septic shock
Skin structure infection
Tinea pedis
Traveler's diarrhea
Tuberculosis
Upper respiratory tract infection
Urinary tract infection

Looking for a partner to support your next infectious disease and vaccines clinical trial?

Our team is ready to help.  Talk with our experts today.